Clinical Trial Update: A Phase 1 Study of GS101 Injection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for GS101 Injection investigating safety and tolerability in Atopic Dermatitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GS101 Injection

Snippet

Sponsor: Jiangsu Genscend Biopharmaceutical Co., Ltd | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: RECRUITING